Access tailored support for your therapeutic programs, from ADCs and cell therapies to targeted protein degraders. In-depth analysis is delivered by scientific teams with a deep understanding of your therapeutic modality.
We deliver the depth and rigor that ADC, cell therapy, and TPD programs demand.
Modality-Specific Expertise
Multi-Omic Capabilities
Global Execution
Custom Assay Design
CAP/CLIA Accredited Labs
CellCarta combined high-plex proteomics with single-cell transcriptomics to characterize antigen-specific T cell responses. Through this integrated workflow, T-cell activation can be investigated as a clinical biomarker for CAR-T therapies, TCE programs, and other immunotherapies.
